Catalogo Articoli (Spogli Riviste)

HELP
ATTENZIONE: attualmente gli articoli Current Contents (fonte ISI) a partire dall'anno 2002 sono consultabili sulla Risorsa On-Line

Le informazioni sugli articoli di fonte ISI sono coperte da copyright

La ricerca find articoli where authors phrase all words ' Lindemann, A' sort by level,fasc_key/DESCEND, pagina_ini_num/ASCEND ha restituito 104 riferimenti
Si mostrano 100 riferimenti a partire da 1
Selezionare un intervallo

Per ulteriori informazioni selezionare i riferimenti di interesse.

    1. Lindemann, A; Kuchinke, J; Koster, C; Hammerschmidt, A; Doch, M; Pruss, T; Krebs, B
      The first perselenoborate with a novel three-dimensional anion network

      PHOSPHORUS SULFUR AND SILICON AND THE RELATED ELEMENTS
    2. Kuchinke, J; Lindemann, A; Koster, C; Hammerschmidt, A; Doch, M; Pruss, T; Krebs, B
      Li(6-x)Cs(x)B(10)Q(18) (Q = S, Se; x similar to 1): New polymeric layered anion networks in chalcogenoborates

      PHOSPHORUS SULFUR AND SILICON AND THE RELATED ELEMENTS
    3. Behringer, D; Schaufler, J; Kresin, V; Lubbert, M; Lindemann, A
      Differentiation associated modulation of the cytokine and chemokine expression pattern in human myeloid cell lines

      LEUKEMIA RESEARCH
    4. Hammerschmidt, A; Lindemann, A; Koster, C; Krebs, B
      Na-6[B18Se17]: The first selenoborato-closo-dodecaborate with a polymeric chain anion

      ZEITSCHRIFT FUR ANORGANISCHE UND ALLGEMEINE CHEMIE
    5. Hammerschmidt, A; Koster, C; Kuper, J; Lindemann, A; Krebs, B
      Novel alkaline earth metal chalcogenoborates: Syntheses and crystal structures of Sr4.2Ba2.8(BS3)(4)S and Ba-7(BSe3)(4)Se

      ZEITSCHRIFT FUR ANORGANISCHE UND ALLGEMEINE CHEMIE
    6. Kuchinke, J; Jansen, C; Lindemann, A; Krebs, B
      Syntheses and crystal structures of the novel ternary thioborates Na3BS3, K3BS3, and Rb3BS3

      ZEITSCHRIFT FUR ANORGANISCHE UND ALLGEMEINE CHEMIE
    7. Lindemann, A; Kuper, J; Jansen, C; Kuchinke, J; Koster, C; Hammerschmidt, A; Doch, M; Pruss, T; Krebs, B
      Syntheses and crystal structures of Rb2B2Se7, Tl2B2Se7, Cs3B3Se10, and Tl3B3Se10: New perseleno-selenoborates with polymeric anionic chains

      ZEITSCHRIFT FUR ANORGANISCHE UND ALLGEMEINE CHEMIE
    8. Lindemann, A; Kuper, J; Hamann, W; Kuchinke, J; Koster, C; Krebs, B
      Syntheses, crystal structures, and properties of the three novel perselenoborates RbBSe3, CsBSe3, and TlBSe3 with polymeric chain anions

      JOURNAL OF SOLID STATE CHEMISTRY
    9. Krause, M; Lindemann, A; Glinski, M; Hornbogen, T; Bonse, G; Jeschke, P; Thielking, G; Gau, W; Kleinkauf, H; Zocher, R
      Directed biosynthesis of new enniatins

      JOURNAL OF ANTIBIOTICS
    10. Lindemann, A
      The 'Letter to the Ephesians'

      BIBLICA
    11. Oelke, M; Moehrle, U; Chen, JL; Behringer, D; Cerundolo, V; Lindemann, A; Mackensen, A
      Generation and purification of CD8(+) Melan-A-specific cytotoxic T lymphocytes for adoptive transfer in tumor immunotherapy

      CLINICAL CANCER RESEARCH
    12. Goryunov, LI; Grobe, J; Shteingarts, VD; Krebs, B; Lindemann, A; Wurthwein, EU; Muck-Lichtenfeld, C
      Trimethylsilyl- and trimethylstannyldimethylphosphane - Convenient and versatile reagents for the synthesis of polyfluoroaryldimethylphosphanes

      CHEMISTRY-A EUROPEAN JOURNAL
    13. Mackensen, A; Drager, R; Schlesier, M; Mertelsmann, R; Lindemann, A
      Presence of IgE antibodies to bovine serum albumin in a patient developinganaphylaxis after vaccination with human peptide-pulsed dendritic cells

      CANCER IMMUNOLOGY IMMUNOTHERAPY
    14. Oelke, M; Kurokawa, T; Hentrich, I; Behringer, D; Cerundolo, V; Lindemann, A; Mackensen, A
      Functional characterization of CD8(+) antigen-specific cytotoxic T lymphocytes after enrichment based on cytokine secretion: Comparison with the MHC-tetramer technology

      SCANDINAVIAN JOURNAL OF IMMUNOLOGY
    15. Mackensen, A; Herbst, B; Chen, JL; Kohler, G; Noppen, C; Herr, W; Spagnoli, GC; Cerundolo, V; Lindemann, A
      Phase I study in melanoma patients of a vaccine with peptide-pulsed dendritic cells generated in vitro from CD34(+) hematopoietic progenitor cells

      INTERNATIONAL JOURNAL OF CANCER
    16. Mackensen, A; Wittnebel, S; Veelken, H; Noppen, C; Spagnoli, GC; Lindemann, A
      Induction and large-scale expansion of CD8(+) tumor specific cytotoxic T lymphocytes from peripheral blood lymphocytes by in vitro stimulation with CD80-transfected autologous melanoma cells

      EUROPEAN CYTOKINE NETWORK
    17. Herrmann, F; Bambach, T; Bonifer, R; Lindemann, A; Riedel, D; Oster, W; Mertelsmann, R
      The suppressive effects of recombinant human tumor necrosis factor-alpha on normal and malignant myelopoiesis: Synergism with interferon-gamma (retraction from the International Journal of Cell Cloning, vol 6, pg 241-261, 1988)

      STEM CELLS
    18. Schreiber, S; Kampgen, E; Wagner, E; Pirkhammer, D; Trcka, J; Korschan, H; Lindemann, A; Dorffner, R; Kittler, H; Kasteliz, F; Kupcu, Z; Sinski, A; Zatloukal, K; Buschle, M; Schmidt, W; Birnstiel, M; Kempe, RE; Voigt, T; Weber, HA; Pehamberger, H; Mertelsmann, R; Brocker, EB; Wolff, K; Stingl, G
      Immunotherapy of metastatic malignant melanoma by a vaccine consisting of autologous interleukin 2 transfected cancer cells: Outcome of a phase I study

      HUMAN GENE THERAPY
    19. Mackensen, A; Krause, T; Blum, U; Uhrmeister, P; Mertelsmann, R; Lindemann, A
      Homing of intravenously and intralymphatically injected human dendritic cells generated in vitro from CD34(+) hematopoietic progenitor cells

      CANCER IMMUNOLOGY IMMUNOTHERAPY
    20. Lahn, M; Fisch, P; Kohler, G; Kunzmann, R; Hentrich, I; Jesuiter, H; Behringer, D; Muschal, B; Veelken, H; Kulmburg, P; Ikle, DN; Lindemann, A
      Pro-inflammatory and T cell inhibitory cytokines are secreted at high levels in tumor cell cultures of human renal cell carcinoma

      EUROPEAN UROLOGY
    21. Lindemann, A; Kuchinke, J; Krebs, B
      Three novel selenoborato-closo-dodecaborates: Syntheses and crystal structures of Rb-8[B-12(BSe3)(6)], Rb4Hg2[B-12(BSe3)(6)], and Cs4Hg2CB12(BSe3)(6)]

      ZEITSCHRIFT FUR ANORGANISCHE UND ALLGEMEINE CHEMIE
    22. Lindemann, A; Schmidt, J
      Heat transfer modeling of a DSC plate transducer

      THERMOCHIMICA ACTA
    23. Osterroth, F; Alkan, O; Mackensen, A; Lindemann, A; Fisch, P; Skerra, A; Veelken, H
      Rapid expression cloning of human immunoglobulin Fab fragments for the analysis of antigen specificity of B cell lymphomas and anti-idiotype lymphomavaccination

      JOURNAL OF IMMUNOLOGICAL METHODS
    24. Wurthner, JU; Kohler, G; Behringer, D; Lindemann, A; Mertelsmann, R; Lubbert, M
      Leukostasis followed by hemorrhage complicating the initiation of chemotherapy in patients with acute myeloid leukemia and hyperleukocytosis - A clinicopathologic report of four cases

      CANCER
    25. Tholey, A; Lindemann, A; Kinzel, V; Reed, J
      Direct effects of phosphorylation on the preferred backbone conformation of peptides: A nuclear magnetic resonance study

      BIOPHYSICAL JOURNAL
    26. SIEBER P; LINDEMANN A; BOEHM M; SEIDEL G; HERZING U; VANDERHEUSEN P; MULLER R; RUGER W; JAENICKE R; ROSCH P
      OVEREXPRESSION AND STRUCTURAL CHARACTERIZATION OF THE PHAGE-T4 PROTEIN DSBA

      Biological chemistry
    27. VEELKEN H; LEUTGEB B; KULMBURG P; FIEBIG HH; MACKENSEN A; LINDEMANN A
      ENHANCEMENT OF A CONSTITUTIVELY ACTIVE PROMOTER FOR GENE-THERAPY BY APOSITIVE FEEDBACK TRANSCRIPTIONAL ACTIVATOR MECHANISM

      INTERNATIONAL JOURNAL OF MOLECULAR MEDICINE
    28. HERBST B; KOHLER G; MACKENSEN A; LINDEMANN A
      IN-VITRO DIFFERENTIATION OF LANGERHANS AND DENDRITIC CELLS

      Bone marrow transplantation
    29. LINDEMANN A; ALKARAWI J; SCHMIDT J
      THERMAL ANALYTICAL STUDY OF STEELS AT HIGH-TEMPERATURE INCLUDING THE RANGE OF MELTING

      Thermochimica acta
    30. MANTOVANI L; HENSCHLER R; BRACH M; WIESER R; LUBBERT M; LINDEMANN A; MERTELSMANN RH; HERRMANN F
      DIFFERENTIAL REGULATION OF INTERLEUKIN-6 EXPRESSION IN HUMAN FIBROBLASTS BY TUMOR-NECROSIS-FACTOR-ALPHA AND LYMPHOTOXIN (VOL 270, PG 156, 1990)

      FEBS letters
    31. HENSCHLER R; LINDEMANN A; BRACH MA; MACKENSEN A; MERTELSMANN RH; HERRMANN F
      EXPRESSION OF FUNCTIONAL RECEPTORS FOR INTERLEUKIN-6 BY HUMAN POLYMORPHONUCLEAR LEUKOCYTES - DOWN-REGULATION BY GRANULOCYTE-MACROPHAGE COLONY-STIMULATING FACTOR (VOL 283, PG 47, 1991)

      FEBS letters
    32. HERBST B; KOHLER G; MACKENSEN A; VEELKEN H; LINDEMANN A
      GM-CSF PROMOTES DIFFERENTIATION OF A PRECURSOR CELL OF MONOCYTES AND LANGERHANS-TYPE DENDRITIC CELLS FROM CD34(+) HEMATOPOIETIC PROGENITOR CELLS

      British Journal of Haematology
    33. WIRTH K; SCHOEPF E; MERTELSMANN R; LINDEMANN A
      LEG ULCERATION WITH ASSOCIATED THROMBOCYTOSIS - HEALING OF ULCERATIONASSOCIATED WITH TREATMENT OF THE RAISED PLATELET COUNT

      British journal of dermatology
    34. Mackensen, A; Lindemann, A; Mertelsmann, R
      Immunostimulatory cytokines in somatic cell and gene therapy

      BIOTHERAPY OF CANCERS
    35. MAHLKNECHT U; VONLINTIG F; MERTELSMANN R; LINDEMANN A; LUBBERT M
      SUCCESSFUL TREATMENT OF DISSEMINATED CENTRAL NERVOUS ASPERGILLOSIS INA PATIENT WITH ACUTE MYELOBLASTIC-LEUKEMIA

      Leukemia & lymphoma
    36. ENGELHARDT M; WIRTH K; MERTELSMANN R; LINDEMANN A; BRENNSCHEIDT U
      CLINICAL AND IMMUNOMODULATORY EFFECTS OF REPETITIVE 2-DAY CYCLES OF HIGH-DOSE CONTINUOUS-INFUSION IL-2

      European journal of cancer
    37. MACKENSEN A; VEELKEN H; LAHN M; WITTNEBEL S; BECKER D; KOHLER G; KULMBURG P; BRENNSCHEIDT U; ROSENTHAL F; FRANKE B; MERTELSMANN R; LINDEMANN A
      INDUCTION OF TUMOR-SPECIFIC CYTOTOXIC T-LYMPHOCYTES BY IMMUNIZATION WITH AUTOLOGOUS TUMOR-CELLS AND INTERLEUKIN-2 GENE TRANSFECTED FIBROBLASTS

      Journal of molecular medicine
    38. KULMBURG P; VEELKEN H; SCHMOOR C; ROSENTHAL FM; MACKENSEN A; LINDEMANN A; MERTELSMANN R
      NTS INFLUENCE ON TRANSGENE EXPRESSION FROM MONOCISTRONIC AND BICISTRONIC PLASMID VECTORS AFTER LIPOFECTION IN A HUMAN FIBROBLAST CELL-LINE

      Journal of molecular medicine
    39. LINDEMANN A; KINZEL V; ROSCH P; REED J
      STRUCTURE OF THE LAV6 PEPTIDE - A NUCLEATION SITE FOR THE CORRECT RECEPTOR-INDUCED REFOLDING OF THE CD4-BINDING DOMAIN OF HIV-1 GP-120

      Proteins
    40. KOHLER G; VEELKEN H; ROSENTHAL F; MACKENSEN A; LINDEMANN A; SCHAEFER HE; LAHN M
      ONCOGENE AND HSP-70 EXPRESSION IN PRIMARY TUMOR-CELL CULTURES OF RENAL-CELL CARCINOMA COMPARED TO THEIR CORRESPONDING CELL-LINE

      Anticancer research
    41. LEO E; SCHLEGEL PG; LINDEMANN A
      CHEMOTHERAPEUTIC INDUCTION OF LONG-TERM REMISSION IN METASTATIC MEDULLOBLASTOMA

      Journal of neuro-oncology
    42. LAHN M; KUNZMANN R; KOHLER G; IKLE DN; HENTRICH I; JESUITER H; KULMBURG P; VEELKEN H; MACKENSEN A; ROSENTHAL F; LINDEMANN A
      COMPARISON OF CYTOGENETICS, CYTOKINE SECRETION, AND ONCOGENE EXPRESSION IN PRIMARY CULTURES OF RENAL-CARCINOMA CELLS

      Oncology
    43. TAMM I; GRIMME H; BERGEN E; SIMON JC; SCHOPF E; MERTELSMANN R; LINDEMANN A; BRENNSCHEIDT U
      DACARBAZINE AND INTERFERON-ALPHA FOR STAGE-IV MALIGNANT-MELANOMA

      Oncology
    44. CLARKE S; LINDEMANN A; MAEDER P; BORRUAT FX; ASSAL G
      FACE RECOGNITION AND POSTERO-INFERIOR HEMISPHERIC LESIONS

      Neuropsychologia
    45. LINDEMANN A; PANG MMH; ZHAO Z
      SHARP BOUNDS FOR GROUND-STATE EIGENFUNCTIONS ON DOMAINS WITH HORNS AND CUSPS

      Journal of mathematical analysis and applications
    46. LINDEMANN A; MERTELSMANN R
      GENE-THERAPY - A REALISTIC APPROACH TO TH E TREATMENT OF MALIGNANT DISEASES

      Der Internist
    47. VEELKEN H; MACKENSEN A; LAHN M; KOHLER G; BECKER D; FRANKE B; BRENNSCHEIDT U; KULMBURG P; ROSENTHAL FM; KELLER H; HASSE J; SCHULTZESEEMANN W; FARTHMANN EH; MERTELSMANN R; LINDEMANN A
      A PHASE-I CLINICAL-STUDY OF AUTOLOGOUS TUMOR-CELLS PLUS INTERLEUKIN-2-GENE-TRANSFECTED ALLOGENEIC FIBROBLASTS AS A VACCINE IN PATIENTS WITHCANCER

      International journal of cancer
    48. LAHN M; KOHLER G; SCHMOOR C; DENGLER W; VEELKEN H; BREENSCHEIDT U; MACKENSEN A; KULMBURG P; HENTRICH I; JESUITER H; ROSENTHAL FM; FIEBIG HH; SOMMERKAMP H; FARTHMANN EH; HASSE J; MERTELSMANN R; LINDEMANN A
      PROCESSING OF TUMOR-TISSUES FOR VACCINATION WITH AUTOLOGOUS TUMOR-CELLS

      European surgical research
    49. HERBST B; KOHLER G; MACKENSEN A; VEELKEN H; MERTELSMANN R; LINDEMANN A
      CD34(-BLOOD PROGENITOR-CELL AND MONOCYTE-DERIVED DENDRITIC CELLS - A COMPARATIVE-ANALYSIS() PERIPHERAL)

      British Journal of Haematology
    50. KADDAR A; EDINGER M; WIRTH K; SCHAEFER HE; LUBBERT M; LINDEMANN A
      INCREASED NUMBERS OF BONE-MARROW BLASTS IN ACUTE MYELOID-LEUKEMIA PATIENTS TREATED WITH G-CSF AFTER CHEMOTHERAPY

      British Journal of Haematology
    51. BEHRINGER D; KRESIN V; HENSCHLER R; MERTELSMANN R; LINDEMANN A
      CYTOKINE AND CHEMOKINE PRODUCTION BY CD34(- DETECTION IN SINGLE CELLS() HEMATOPOIETIC PROGENITOR CELLS )

      British Journal of Haematology
    52. HERBST B; KOHLER G; MACKENSEN A; VEELKEN H; LINDEMANN A
      CD34(-BLOOD PROGENITOR CELL-DERIVED AND MONOCYTE-DERIVED DENDRITIC CELLS - A COMPARATIVE-ANALYSIS() PERIPHERAL)

      Blood
    53. HERBST B; KOHLER G; MACKENSEN A; VEELKEN H; LINDEMANN A
      GM-CSF PROMOTES DIFFERENTIATION OF A COMMON PROGENITOR OF MONOCYTES AND LANGERHANS-TYPE DENDRITIC CELLS FROM CD34(+) HEMATOPOIETIC PROGENITOR CELLS

      Blood
    54. VEELKEN K; OSTERROTH F; LINDEMANN A; MERTELSMANN R
      RAPID EXPRESSION CLONING OF B-CELL LYMPHOMA-DERIVED IMMUNOGLOBULIN GENES FOR ANTIIDIOTYPIC VACCINATION AND FUNCTIONAL ANALYSES OF FAB-FRAGMENTS

      Blood
    55. LINDEMANN A; MERTELSMANN R
      MOLECULAR MEDICINE - FROM GENE TO TREATME NT

      Deutsche Medizinische Wochenschrift
    56. ROSENTHAL FM; KULMBURG P; FRUH R; PFEIFER C; VEELKEN H; MACKENSEN A; KOHLER G; LINDEMANN A; MERTELSMANN R
      SYSTEMIC HEMATOLOGICAL EFFECTS OF GRANULOCYTE-COLONY-STIMULATING FACTOR PRODUCED BY IRRADIATED GENE-TRANSFECTED FIBROBLASTS

      Human gene therapy
    57. VEELKEN H; RE D; KULMBURG P; ROSENTHAL FM; MACKENSEN A; MERTELSMANN R; LINDEMANN A
      SYSTEMATIC EVALUATION OF CHIMERIC MARKER GENES ON DICISTRONIC TRANSCRIPTION UNITS FOR REGULATED EXPRESSION OF TRANSGENES IN-VITRO AND IN-VIVO

      Human gene therapy
    58. STRACKE H; LINDEMANN A; FEDERLIN K
      A BENFOTIAMINE-VITAMIN-B COMBINATION IN TREATMENT OF DIABETIC POLYNEUROPATHY

      EXPERIMENTAL AND CLINICAL ENDOCRINOLOGY & DIABETES
    59. ENGELHARDT M; BRENNSCHEIDT U; MERTELSMANN R; LINDEMANN A
      INTERLEUKIN-10 AND PHENOMENA OF TOLERANCE IN INTERLEUKIN-2

      Journal of clinical oncology
    60. ENGELHARDT M; BRENNSCHEIDT U; MERTELSMANN R; LINDEMANN A
      INTERLEUKIN-10 AND PHENOMENA OF TOLERANCE IN INTERLEUKIN-2 THERAPY

      Experimental hematology
    61. ENGELHARDT R; FINKE J; KULMBURG P; LANGE W; LINDEMANN A; MACKENSEN A; MARTELSMANN R; ROSENTHAL F; VEELKEN H
      SOMATIC-CELL AND GENE-THERAPY - PERSPECTIVES IN ONCOLOGY

      Naunyn-Schmiedeberg's archives of pharmacology
    62. FABER C; LINDEMANN A; STICHT H; EJCHART A; KUNGL A; SUSANI M; FRANK RW; KRAFT D; BREITENBACH M; ROSCH P
      SECONDARY STRUCTURE AND TERTIARY FOLD OF THE BIRCH POLLEN ALLERGEN BET-V-1 IN SOLUTION

      The Journal of biological chemistry
    63. BEHRINGER DM; SUNDERER B; ANDERSSON U; KRESIN V; MERTELSMANN R; LINDEMANN A
      SIMULTANEOUS DETECTION OF CYTOKINE AND IMMUNOPHENOTYPE AT THE SINGLE-CELL LEVEL BY IMMUNOENZYMATIC DOUBLE STAINING

      Histochemical Journal
    64. MOELLMANN HW; HOCHHAUS G; TROMM A; MOELLMANN A; DERENDORF H; BARTH J; FROEHLICH P; ECKER KW; LINDEMANN A
      PHARMACOKINETICS AND EVALUATION OF SYSTEMIC SIDE-EFFECTS OF BUDESONIDE AFTER ORAL-ADMINISTRATION OF MODIFIED RELEASE CAPSULES IN HEALTHY-VOLUNTEERS, ILEOSTOMA PATIENTS AND PATIENTS WITH CROHNS-DISEASE

      Gastroenterology
    65. HERBST B; KOHLER G; MACKENSEN A; VEELKEN H; KULMBURG P; ROSENTHAL FM; SCHAEFER HE; MERTELSMANN R; FISCH P; LINDEMANN A
      IN-VITRO DIFFERENTIATION OF CD34(-POSITIVE LANGERHANS CELL AND THE INTERDIGITATING DENDRITIC CELL-TYPE() HEMATOPOIETIC PROGENITOR CELLS TOWARD DISTINCT DENDRITIC CELL SUBSETS OF THE BIRBECK GRANULE AND MIIC)

      Blood
    66. BEHRINGER DM; KRESIN V; HENSCHLER R; MERTELSMANN R; LINDEMANN A
      CYTOKINE AND CHEMOKINE PRODUCTION BY CD34(- DETECTION AT THE SINGLE-CELL LEVEL() HEMATOPOIETIC PROGENITOR CELLS )

      Blood
    67. LINDEMANN A; KOHLER G; MACKENSEN A; VEELKEN H; ROSENTHAL FM; SCHAEFER HE; FISCH P; MERTELSMANN R; HERBST B
      IN-VITRO DIFFERENTIATION OF CD34(-POSITIVE LANGERHANS CELL AND THE INTERDIGITATING DENDRITIC CELL-TYPE() HEMATOPOIETIC PROGENITOR CELLS TOWARDS DISTINCT DENDRITIC CELL SUBSETS OF THE MIIC)

      Blood
    68. HEIL G; HERRMANN F; HOELZER D; SEIPELT G; EDER M; HUBER C; KOLBE K; MERTELSMANN R; LINDEMANN A; FRISCH J; NICOLAY C; GAUS W; HEIMPEL H
      GM-CSF PRIMING IN THE THERAPY OF DE-NOVO AML PATIENTS - AN UPDATE OF A DOUBLE-BLIND RANDOMIZED PLACEBO-CONTROLLED

      Blood
    69. KUNGL AJ; SUSANI M; LINDEMANN A; MACHIUS M; VISSER AJWG; SCHEINER O; KRAFT D; BREITENBACH M; AUER M
      EVIDENCE FOR AN ALPHA-HELICAL T-CELL EPITOPE IN THE C-TERMINUS OF THEMAIN BIRCH POLLEN ALLERGEN BET-V-1

      Biochemical and biophysical research communications
    70. ROSENTHAL FM; FRUH R; KOHLER G; KULMBURG P; VEELKEN H; MACKENSEN A; LINDEMANN A; MERTELSMANN R
      CYTOKINE GENE-THERAPY WITH GENE TRANSFECTED CELLS - LONG-TERM EXPRESSION IN-VIVO AND THERAPEUTIC POTENTIAL

      European journal of cancer
    71. MERTELSMANN R; LINDEMANN A; BOEHM T; BRENNSCHEIDT U; FRANKE B; KULMBURG P; LAHN M; MACKENSEN A; ROSENTHAL FM; VEELKEN H
      PILOT-STUDY FOR THE EVALUATION OF T-CELL-MEDIATED TUMOR-IMMUNOTHERAPYBY CYTOKINE GENE-TRANSFER IN PATIENTS WITH MALIGNANT-TUMORS

      Journal of molecular medicine
    72. LINDEMANN A; ROSENTHAL FM; HASE S; MARKMEYER P; MERTELSMANN R
      GUIDELINES FOR THE DESIGN AND IMPLEMENTATION OF CLINICAL-STUDIES IN SOMATIC-CELL THERAPY AND GENE-THERAPY

      Journal of molecular medicine
    73. ENGELHARDT M; RUMP JA; HELLERICH U; MERTELSMANN R; LINDEMANN A
      LEUKOCYTOCLASTIC VASCULITIS AND LONG-TERM REMISSION IN A PATIENT WITHSECONDARY AML AND POSTREMISSION TREATMENT WITH LOW-DOSE INTERLEUKIN-2

      Annals of hematology
    74. HEIL G; CHADID L; HOELZER D; SEIPELT G; MITROU P; HUBER C; KOLBE K; MERTELSMANN R; LINDEMANN A; FRISCH J; NICOLAY U; GAUS W; HEIMPEL H
      GM-CSF IN A DOUBLE-BLIND RANDOMIZED, PLACEBO-CONTROLLED TRIAL IN THERAPY OF ADULT PATIENTS WITH DE-NOVO ACUTE MYELOID-LEUKEMIA (AML)

      Leukemia
    75. LEE E; KROPFF M; LINDEMANN A; STEINFURTH G; ESSELBORN H; ROSSNER R; ADLER CP; BOCKING A
      DNA ANEUPLOIDY, INCREASED PROLIFERATION AND NUCLEAR-AREA OF PLASMA-CELLS IN MONOCLONAL GAMMOPATHY OF UNDETERMINED SIGNIFICANCE AND MULTIPLE-MYELOMA

      Analytical and quantitative cytology and histology
    76. VEELKEN H; KULMBURG P; ROSENTHAL FM; MACKENSEN A; MERTELSMANN R; LINDEMANN A
      NONVIRAL EX-VIVO TRANSFECTION OF PRIMARY HUMAN SKIN FIBROBLASTS FOR GENE-THERAPY

      Journal of cellular biochemistry
    77. LINDEMANN A; ROSENTHAL FM; HASE S; MARKMEYER P; MERTELSMANN R
      HINTS ON THE PLANNING AND IMPLEMENTATION OF CLINICAL-STUDIES IN THE AREA OF SOMATIC-CELL AND GENE-THERAPY

      Medizinische Klinik
    78. LINDEMANN A; ROSENTHAL FM; HASE S; MARKMEYER P; MERTELSMANN R
      NOTES ON THE PLANNING AND IMPLEMENTATION OF CLINICAL-TRIALS IN THE FIELDS OF SOMATIC-CELL AND GENE-THERAPY

      Onkologie
    79. MACKENSEN A; HERBST B; KOHLER G; WOLFFVORBECK G; ROSENTHAL F; VEELKEN H; KULMBURG P; SCHAEFER HE; MERTELSMANN R; LINDEMANN A
      DELINEATION OF THE DENTRITIC CELL LINEAGE BY GENERATING BIRBECK GRANULE-POSITIVE LANGERHANS CELLS FROM HUMAN PERIPHERAL-BLOOD PROGENITOR CELLS IN-VITRO

      Experimental hematology
    80. HERBST B; MACKENSEN A; KOHLER G; WOLFFVORBECK G; HENSCHLER R; MERTELSMANN R; LINDEMANN A; FISCH P
      POTENT PRESENTATION OF SOLUBLE-PROTEIN ANTIGENS BY IN-VITRO GENERATEDDENDRITIC CELLS FROM PERIPHERAL-BLOOD CD34-PATIENTS( PROGENITOR CELLSOF CANCER)

      Experimental hematology
    81. LINDEMANN A; VEELKEN H; MACKENSEN A; BRENNSCHEIDT U; KULMBURG P; ROSENTHAL FM; LAHN M; MERTELSMANN R
      TUMORIMMUNOTHERAPY WITH INTERLEUKIN-2 GENE TRANSFECTED FIBROBLASTS - A PHASE-I STUDY

      Experimental hematology
    82. LINDEMANN A
      THE CHURCH AS THE BODY - OBSERVATIONS ON SO-CALLED DEMOCRATIC ECCLESIOLOGY ACCORDING TO THE APOSTLE PAUL

      Zeitschrift fur Theologie und Kirche
    83. LINDEMANN A; TAMM I; TANODI K; MERTELSMANN R
      INTERLEUKIN-8 SERUM LEVELS FOR EARLY DETECTION OF INFECTIOUS EPISODESIN NEUTROPENIC PATIENTS

      The Journal of infectious diseases
    84. LINDEMANN A; ROSENTHAL FM; HASE S; MARKMEYER P; MERTELSMANN R
      GUIDE FOR PLANNING AND IMPLEMENTING CLINI CAL-STUDIES IN THE AREAS OFSOMATIC-CELL AND GENE-THERAPY

      Chirurg
    85. KRUIT WHJ; GOEY SH; CALABRESI F; LINDEMANN A; STAHEL RA; POLIWODA H; OSTERWALDER B; STOTER G
      FINAL REPORT OF A PHASE-II STUDY OF INTERLEUKIN-2 AND INTERFERON ALPHA IN PATIENTS WITH METASTATIC MELANOMA

      British Journal of Cancer
    86. MACKENSEN A; HERBST B; KOHLER G; WOLFFVORBECK G; ROSENTHAL FM; VEELKEN H; KULMBURG P; SCHAEFER HE; MERTELSMANN R; LINDEMANN A
      DELINEATION OF THE DENDRITIC CELL LINEAGE BY GENERATING LARGE NUMBERSOF BIRBECK GRANULE-POSITIVE LANGERHANS CELLS FROM HUMAN PERIPHERAL-BLOOD PROGENITOR CELLS IN-VITRO

      Blood
    87. LINDEMANN A; HERBST B; KOEHLER G; ROSENTHAL F; VEELKEN H; KULMBURG P; MERTELSMANN R; MACKENSEN A
      GENERATION OF BIRBECK GRANULE-POSITIVE LANGERHANS CELLS FROM HUMAN PERIPHERAL-BLOOD PROGENITOR CELLS IN-VITRO

      Blood
    88. LINDEMANN A; BROSSART P; HOFFKEN K; FLASSHOVE M; VOLIOTIS D; DIEHL V; KULMBURG P; WAGNER H; MERTELSMANN R
      SERUM CYTOKINE LEVELS IN CANCER-PATIENTS TREATED WITH DIFFERENT SCHEDULES OF ULTRA-LOW-DOSE INTERLEUKIN-2

      Journal of immunotherapy with emphasis on tumor immunology
    89. VEELKEN H; JESUITER H; MACKENSEN A; KULMBURG P; SCHULTZE J; ROSENTHAL F; MERTELSMANN R; LINDEMANN A
      PRIMARY FIBROBLASTS FROM HUMAN ADULTS AS TARGET-CELLS FOR EX-VIVO TRANSFECTION AND GENE-THERAPY

      Human gene therapy
    90. BRENNSCHEIDT U; LINDEMANN A
      CYTOKINES IN CLINICAL CANCER-TREATMENT TRIALS - METHODOLOGICAL ASPECTS

      European journal of cancer
    91. BLUM U; WINDFUHR M; BUITRAGOTELLEZ C; STOVER B; KREISEL B; LINDEMANN A; HERBST EW; LANGER M
      NODULAR PULMONARY-LESIONS IN IMMUNOCOMPRO MISED PATIENTS

      RoFo. Fortschritte auf dem Gebiete der Rontgenstrahlen und der neuenbildgebenden Verfahren
    92. DIGEL W; SCHULTZE J; KUNZMANN R; MERTELSMANN R; LINDEMANN A
      POOR-PROGNOSIS OF PRETHYMIC PHENOTYPE ACUTE LYMPHOBLASTIC-LEUKEMIA (PRE-T-ALL)

      Leukemia
    93. ROSENTHAL FM; SCHULTZE J; VEELKEN H; KULMBURG P; KOHLER G; CRONIN K; LINDEMANN A; MERTELSMANN R; GANSBACHER B
      EFFECTS OF AUTOCRINE AND PARACRINE SECRETION OF CYTOKINES ON INDUCTION OF ANTITUMOR IMMUNITY

      Journal of cellular biochemistry
    94. VEELKEN H; JESUITER H; KNOBLICH J; LOHNER H; SCHULTZE J; MERTELSMANN R; LINDEMANN A
      ROUTINE ESTABLISHMENT OF DIPLOID FIBROBLAST-CULTURES FROM HUMAN ADULTS AS POTENTIAL TARGET-CELLS FOR GENE-TRANSFER

      Journal of cellular biochemistry
    95. DEVRIES J; SCHEREMET R; ALTMANNSBERGER M; MICHILLI R; LINDEMANN A; HINKELBEIN W
      PRIMARY LEIOMYOSARCOMA OF THE SPINAL LEPTOMENINGES

      Journal of neuro-oncology
    96. ROSENTHAL FM; FRUH R; HENSCHLER R; VEELKEN H; KULMBURG P; MACKENSEN A; GANSBACHER B; MERTELSMANN R; LINDEMANN A
      CYTOKINE THERAPY WITH GENE-TRANSFECTED CELLS - SINGLE INJECTION OF IRRADIATED GRANULOCYTE-MACROPHAGE COLONY-STIMULATING FACTOR-TRANSDUCED CELLS ACCELERATES HEMATOPOIETIC RECOVERY AFTER CYTOTOXIC CHEMOTHERAPY IN MICE

      Blood
    97. ROSENTHAL FM; FRUH R; HENSCHLER R; VEELKEN H; KULMBURG P; MACKENSEN A; GANSBACHER B; MERTELSMANN R; LINDEMANN A
      CYTOKINE THERAPY WITH GENE-TRANSFECTED CELLS - SINGLE INJECTION OF IRRADIATED GRANULOCYTE-MACROPHAGE COLONY-STIMULATING FACTOR-TRANSDUCED CELLS ACCELERATES HEMATOPOIETIC RECOVERY AFTER CYTOTOXIC CHEMOTHERAPY IN MICE

      Blood
    98. LINDEMANN A; MERTELSMANN R
      SCHEDULING OF ULTRA-LOW DOSE INTERLEUKIN-2 IN IMMUNOTHERAPY

      European journal of cancer
    99. LINDEMANN A; RUMBERGER B
      VASCULAR COMPLICATIONS IN PATIENTS TREATED WITH GRANULOCYTE-COLONY-STIMULATING FACTOR (G-CSF)

      European journal of cancer
    100. GANSER A; OTTMANN OG; SEIPELT G; LINDEMANN A; HESS U; GEISSLER G; MAURER A; FRISCH J; SCHULZ G; MERTELSMANN R; HOELZER D
      EFFECT OF LONG-TERM TREATMENT WITH RECOMBINANT HUMAN INTERLEUKIN-3 INPATIENTS WITH MYELODYSPLASTIC SYNDROMES

      Leukemia


ASDD Area Sistemi Dipartimentali e Documentali, Università di Bologna, Catalogo delle riviste ed altri periodici
Documento generato il 07/08/20 alle ore 23:01:17